ALIPEMETINIB – Pemigatinib

Pemigatinib is listed in the VetinoPharma B2B pharmaceutical product catalog under Oncology. It is commonly referenced in treatment areas related to fgfr2 fusion or rearrangement cholangiocarcinoma reference; other fgfr contexts require review and should be reviewed for the relevant market, documentation, and intended business context. For wholesale, distribution, or sourcing inquiries, please contact the VetinoPharma team.